高效价亚洲1型口蹄疫疫苗对羊异源攻击的保护
研究用高效价(>6 PD50)亚洲1型Shamir疫苗接种羊,分别在接种后21、7、4天用亚洲1型/PAK/19/2014分离株经鼻咽滴注攻击。接种后21天和7天组羊均无临床口蹄疫,接种后4天组羊全部发生全身感染;接种减少病毒排出但未影响持续感染。
要点
- 接种后21天和7天攻击的羊均无临床口蹄疫,接种后4天攻击的羊全部全身感染。
- 接种后21天组80%羊、接种后7天组40%羊获无菌免疫,接种后4天组无。
- 接种减少鼻和口腔分泌物排毒,但对持续感染无影响。
核心结论
- 高效价亚洲1型Shamir疫苗在疫情暴发时可保护羊免于临床口蹄疫。
- 鼻咽滴注是羊疫苗效力研究的有效攻击方法。
研究设计与样本
- 每组5只羊,用高效价(>6 PD50)亚洲1型Shamir疫苗接种后21、7或4天经鼻咽滴注亚洲1型/PAK/19/2014分离株攻击。
- 另设5只仅佐剂模拟接种羊于攻击前4天接种,及5只未接种对照羊同样攻击。
主要发现
- 接种后21天、7天和4天组羊均无临床口蹄疫。
- 接种后21天组80%羊和接种后7天组40%羊获无菌免疫,接种后4天组全部羊全身感染。
- 接种减少鼻和口腔分泌物病毒排出,但对持续感染发展无影响。
- 仅佐剂模拟接种组和未接种对照组羊全部发生临床口蹄疫。
关键数值与推荐
- 疫苗效价>6 PD50。
- 接种后21天组无菌免疫80%,接种后7天组40%,接种后4天组0%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Foot-and-mouth disease virus (FMDV) serotype Asia-1 is prevalent in countries considered high risk for incursion into Australia, and has recently been responsible for a number of outbreaks in India, Bangladesh, Pakistan and Turkey. In vitro vaccine matching has shown a number of contemporary FMDV Asia-1 strains vary antigenically to the Asia-1 Shamir vaccine strain, which could result in poor protection with use of this vaccine. Therefore it was important to test the ability of the Asia-1 Shamir vaccine to protect sheep from challenge with a recent, heterologous strain at different days post-vaccination (dpv), including in an emergency vaccination scenario (challenge 4 or 7 dpv). Sheep (5 per group) were challenged with the Asia-1/PAK/19/2014 isolate by intra-nasopharyngeal instillation 21 (V21), 7 (V7) or 4 (V4) dpv with high-potency (>6 PD50) Asia-1 Shamir vaccine. An additional five sheep were mock-vaccinated with adjuvant only (antigen-free preparation) 4 days prior to challenge (A4), and five unvaccinated (UV) control sheep were also challenged. All V21, V7 and V4 sheep were protected from clinical FMD. Eighty percent of V21 sheep and 40% of V7 sheep had sterile immunity, however all V4 sheep became systemically infected. Vaccination reduced excretion of virus in nasal and oral secretions but had no effect on the development of persistent infection. All A4 sheep and UV control sheep developed clinical FMD. The high-potency Asia-1 Shamir vaccine will protect against disease should an outbreak of contemporary Asia-1 viruses occur. Intranasopharyngeal instillation is an effective challenge method for use in vaccine efficacy studies in sheep.
引用
- Horsington J, Nfon C, Gonzales JL, et al. Protection in sheep against heterologous challenge with serotype Asia-1 foot-and-mouth disease virus using high potency vaccine. Vaccine. 2018. PMID: 30195485. doi:10.1016/j.vaccine.2018.08.073
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。